A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT05421663 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05421663
Sponsor: Janssen Research & Development, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Start date: 2022-08-12
Primary completion: 2028-12-29
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.